Literature DB >> 21889355

Androgen receptor-driven chromatin looping in prostate cancer.

Dayong Wu1, Chunpeng Zhang, Yanping Shen, Kenneth P Nephew, Qianben Wang.   

Abstract

The androgen receptor (AR) is important for prostate cancer development and progression. Genome-wide mapping of AR binding sites in prostate cancer has found that the majority of AR binding sites are located within non-promoter regions. These distal AR binding regions regulate AR target genes (e.g. UBE2C) involved in prostate cancer growth through chromatin looping. In addition to long-distance gene regulation, looping has been shown to induce spatial proximity of two genes otherwise located far away along the genomic sequence and the formation of double-strand DNA breaks, resulting in aberrant gene fusions (e.g. TMPRSS2-ERG) that also contribute to prostate tumorigenesis. Elucidating the mechanisms of AR-driven chromatin looping will increase our understanding of prostate carcinogenesis and may lead to the identification of new therapeutic targets.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21889355      PMCID: PMC3229688          DOI: 10.1016/j.tem.2011.07.006

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  76 in total

Review 1.  Origin of chromosomal translocations in lymphoid cancer.

Authors:  André Nussenzweig; Michel C Nussenzweig
Journal:  Cell       Date:  2010-04-02       Impact factor: 41.582

2.  An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progression.

Authors:  Jindan Yu; Jianjun Yu; Ram-Shankar Mani; Qi Cao; Chad J Brenner; Xuhong Cao; Xiaoju Wang; Longtao Wu; James Li; Ming Hu; Yusong Gong; Hong Cheng; Bharathi Laxman; Adaikkalam Vellaichamy; Sunita Shankar; Yong Li; Saravana M Dhanasekaran; Roger Morey; Terrence Barrette; Robert J Lonigro; Scott A Tomlins; Sooryanarayana Varambally; Zhaohui S Qin; Arul M Chinnaiyan
Journal:  Cancer Cell       Date:  2010-05-18       Impact factor: 31.743

3.  Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma.

Authors:  Nallasivam Palanisamy; Bushra Ateeq; Shanker Kalyana-Sundaram; Dorothee Pflueger; Kalpana Ramnarayanan; Sunita Shankar; Bo Han; Qi Cao; Xuhong Cao; Khalid Suleman; Chandan Kumar-Sinha; Saravana M Dhanasekaran; Ying-bei Chen; Raquel Esgueva; Samprit Banerjee; Christopher J LaFargue; Javed Siddiqui; Francesca Demichelis; Peter Moeller; Tarek A Bismar; Rainer Kuefer; Douglas R Fullen; Timothy M Johnson; Joel K Greenson; Thomas J Giordano; Patrick Tan; Scott A Tomlins; Sooryanarayana Varambally; Mark A Rubin; Christopher A Maher; Arul M Chinnaiyan
Journal:  Nat Med       Date:  2010-06-06       Impact factor: 53.440

4.  Integrative genomic profiling of human prostate cancer.

Authors:  Barry S Taylor; Nikolaus Schultz; Haley Hieronymus; Anuradha Gopalan; Yonghong Xiao; Brett S Carver; Vivek K Arora; Poorvi Kaushik; Ethan Cerami; Boris Reva; Yevgeniy Antipin; Nicholas Mitsiades; Thomas Landers; Igor Dolgalev; John E Major; Manda Wilson; Nicholas D Socci; Alex E Lash; Adriana Heguy; James A Eastham; Howard I Scher; Victor E Reuter; Peter T Scardino; Chris Sander; Charles L Sawyers; William L Gerald
Journal:  Cancer Cell       Date:  2010-06-24       Impact factor: 31.743

5.  Research Resource: The androgen receptor modulates expression of genes with critical roles in muscle development and function.

Authors:  Anastasia Wyce; Yuchen Bai; Sunil Nagpal; Catherine C Thompson
Journal:  Mol Endocrinol       Date:  2010-07-07

Review 6.  Partners in crime: deregulation of AR activity and androgen synthesis in prostate cancer.

Authors:  Karen E Knudsen; Trevor M Penning
Journal:  Trends Endocrinol Metab       Date:  2010-02-06       Impact factor: 12.015

7.  The dangers of transcription.

Authors:  Stephan Mathas; Tom Misteli
Journal:  Cell       Date:  2009-12-11       Impact factor: 41.582

8.  Nucleosome dynamics define transcriptional enhancers.

Authors:  Housheng Hansen He; Clifford A Meyer; Hyunjin Shin; Shannon T Bailey; Gang Wei; Qianben Wang; Yong Zhang; Kexin Xu; Min Ni; Mathieu Lupien; Piotr Mieczkowski; Jason D Lieb; Keji Zhao; Myles Brown; X Shirley Liu
Journal:  Nat Genet       Date:  2010-03-07       Impact factor: 38.330

9.  Overexpression of the E2 ubiquitin-conjugating enzyme UbcH10 causes chromosome missegregation and tumor formation.

Authors:  Janine H van Ree; Karthik B Jeganathan; Liviu Malureanu; Jan M van Deursen
Journal:  J Cell Biol       Date:  2010-01-11       Impact factor: 10.539

10.  Nuclear receptor-induced chromosomal proximity and DNA breaks underlie specific translocations in cancer.

Authors:  Chunru Lin; Liuqing Yang; Bogdan Tanasa; Kasey Hutt; Bong-gun Ju; Kenny Ohgi; Jie Zhang; David W Rose; Xiang-Dong Fu; Christopher K Glass; Michael G Rosenfeld
Journal:  Cell       Date:  2009-12-11       Impact factor: 41.582

View more
  28 in total

1.  Targeted radiosensitization of ETS fusion-positive prostate cancer through PARP1 inhibition.

Authors:  Sumin Han; J Chad Brenner; Aaron Sabolch; Will Jackson; Corey Speers; Kari Wilder-Romans; Karen E Knudsen; Theodore S Lawrence; Arul M Chinnaiyan; Felix Y Feng
Journal:  Neoplasia       Date:  2013-10       Impact factor: 5.715

2.  Hormone-induced and DNA demethylation-induced relief of a tissue-specific and developmentally regulated block in transcriptional elongation.

Authors:  Manjeet K Rao; Yuiko Matsumoto; Marcy E Richardson; Subbarayalu Panneerdoss; Anjana Bhardwaj; Jacqueline M Ward; Sreenath Shanker; Anilkumar Bettegowda; Miles F Wilkinson
Journal:  J Biol Chem       Date:  2014-10-20       Impact factor: 5.157

3.  Mapping mutations in prostate cancer exomes.

Authors:  Benjamin Sunkel; Qianben Wang
Journal:  Asian J Androl       Date:  2012-07-30       Impact factor: 3.285

Review 4.  Recurrent rearrangements in prostate cancer: causes and therapeutic potential.

Authors:  Nicole M White; Felix Y Feng; Christopher A Maher
Journal:  Curr Drug Targets       Date:  2013-04       Impact factor: 3.465

Review 5.  Getting down to the core of histone modifications.

Authors:  Antonia P M Jack; Sandra B Hake
Journal:  Chromosoma       Date:  2014-05-02       Impact factor: 4.316

Review 6.  Physiology of the read-write genome.

Authors:  James A Shapiro
Journal:  J Physiol       Date:  2014-06-01       Impact factor: 5.182

Review 7.  Interrogating genomic and epigenomic data to understand prostate cancer.

Authors:  Jung Kim; Jindan Yu
Journal:  Biochim Biophys Acta       Date:  2012-01-03

Review 8.  Androgen receptor gene rearrangements: new perspectives on prostate cancer progression.

Authors:  Lucas J Brand; Scott M Dehm
Journal:  Curr Drug Targets       Date:  2013-04       Impact factor: 3.465

9.  The cistrome and gene signature of androgen receptor splice variants in castration resistant prostate cancer cells.

Authors:  Ji Lu; Peter E Lonergan; Lucas P Nacusi; Liguo Wang; Lucy J Schmidt; Zhifu Sun; Travis Van der Steen; Stephen A Boorjian; Farhad Kosari; George Vasmatzis; George G Klee; Steven P Balk; Haojie Huang; Chunxi Wang; Donald J Tindall
Journal:  J Urol       Date:  2014-08-14       Impact factor: 7.450

Review 10.  The oncogene ERG: a key factor in prostate cancer.

Authors:  P Adamo; M R Ladomery
Journal:  Oncogene       Date:  2015-04-27       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.